Emcure Pharmaceuticals has received approval for incorporation of a wholly-owned subsidiary (WOS) by the name ‘Emcure Generics’ in Pune, Maharashtra, India. The WOS is being incorporated to manufacture, promote, sale and distribute pharmaceuticals and other related product(s).
The Board of Directors of the company in their meeting held May 22, 2025, has approved the same.
Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.